본문바로가기

COMPANY

Thank you for visiting the MiCo BioMed Homepage and welcome!

Ever since MiCo BioMed was founded in 2009, we have been focusing on one mission statement: healthcare for everyone, everywhere. We work hard knowing that molecular diagnostics is critical in achieving global health and happiness. We are striving to overcome the limits of existing devices and reagents with our Lab-On-A-Chip based technology so we can carry out POCT (Point-Of-Care-Testing) quickly and accurately. Since early 2020 we have been able to show unprecedented growth on the back of worldwide spread of COVID-19 pandemic. Moreover, we have successfully completed our IPO on KOSDAQ. Recently we are closely keeping track of worldwide COVID-19 vaccination status and continuous emergences of new COVID-19 variants. Now preparing ourselves for a post-COVID era, we are growing and evolving to be the leader in the global POCT market. We deeply appreciate your interest and support for our company.

U-Healthcare

We strive for global leadership
in U-Healthcare through
molecular diagnostics.
MiCo BioMed., Ltd.CEO
Sung woo
Kim

Columbia University Ph. D

Former Harvard Medical School Research Professor

Former Tufts University School of Medicine Research Professor